story of the week
Incretin-Based Drugs and Risk of Cholangiocarcinoma Among Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
BMJ: British Medical Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Incretin Based Drugs and Risk of Cholangiocarcinoma Among Patients With Type 2 Diabetes: Population Based Cohort Study
BMJ 2018 Dec 05;363(xx)k4880, D Abrahami, A Douros, H Yin, OH Yu, JL Faillie, F Montastruc, RW Platt, N Bouganim, L AzoulayFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.